Q2 2025 Holdings
Filed 2025-08-14 | 35 holdings | $536.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $37.5M | 372,672 | 7.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $29.3M | 309,988 | 5.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $26.8M | 527,540 | 5.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $24.5M | 320,798 | 4.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $24.2M | 43,953 | 4.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $23.8M | 551,684 | 4.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $23.2M | 134,687 | 4.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $20.7M | 660,617 | 3.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $20.4M | 2,009,923 | 3.8% |
| Natera Inc(NTRA) | COM | 632307104 | $20.0M | 118,130 | 3.7% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $19.9M | 1,092,361 | 3.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $17.6M | 32,305 | 3.3% |
| Insulet Corp(PODD) | COM | 45784P101 | $16.2M | 51,408 | 3.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $16.1M | 447,884 | 3.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $15.9M | 299,464 | 3.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $15.7M | 302,307 | 2.9% |
| Merus N V | COM | N5749R100 | $15.4M | 292,964 | 2.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $15.3M | 415,591 | 2.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $15.1M | 144,400 | 2.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $14.9M | 138,834 | 2.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $14.2M | 215,223 | 2.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $13.5M | 311,490 | 2.5% |
| Radnet Inc(RDNT) | COM | 750491102 | $11.3M | 197,759 | 2.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $10.3M | 447,420 | 1.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $10.2M | 509,987 | 1.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $9.4M | 521,097 | 1.8% |
| Healthequity Inc(HQY) | COM | 42226A107 | $8.5M | 80,880 | 1.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $8.0M | 455,953 | 1.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $7.3M | 309,666 | 1.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $7.2M | 86,332 | 1.3% |
| Harrow Inc(HROW) | COM | 415858109 | $7.0M | 228,761 | 1.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $6.1M | 114,554 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.8M | 17,879 | 1.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.4M | 214,138 | 0.5% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $2.3M | 157,194 | 0.4% |